(TheNewswire)
Toronto, Ontario / TheNewswire / April 1,
2019 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”,
TSXV:VPT, OTCQB:VPTDF) is pleased to announce that they are a proud sponsor of the 21st Annual
Canadian Society of Echocardiography Annual Symposium and will be exhibiting the VMS+ 3.0 system.
The annual symposium is being held at the Toronto Marriott Downtown Eaton Centre Hotel from April
11th – 13th, 2019. It will explore
aspects of interventional echocardiography and structural heart disease, the developing role of artificial intelligence in echo and
cardiac imaging as well as a session on congenital heart disease.
“As one of the largest echo meetings in North America, we are looking forward to meeting with
industry leading clinicians for a hands-on demonstration of the VMS+ 3.0. The compact and portable system
can be set-up within minutes and fits seamlessly into the echocardiography workflow. This meeting will provide an excellent
opportunity to showcase the system to our target demographic and aligns well with our strategic pre-launch plans,” commented
Jessica Naman, Marketing Manager at Ventripoint Diagnostics.
The VMS+ 3.0 system is designed to create 3D calculations for volumetric measurements and ejection
fractions from standard 2D echo views for all four chambers of the heart with the of use Artificial Intelligence (AI).
The VMS+3.0 system is not commercially available for sale. For investigational use only.
About Ventripoint Diagnostics Ltd.
Ventripoint’s technology is a leading Artificial Intelligence (AI) approach known as Knowledge-Based
Reconstruction (KBR), used to create applications to monitor heart disease, a leading cause of death worldwide. The VMS+ is the
first cost-effective and accurate AI tool for measuring whole heart function using conventional ultrasound. The Company has
developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac
care.
For further information please contact:
Dr. George Adams, CEO, Telephone: (519) 803-6937
Email: gadams@ventripoint.com
Forward Looking Statements:
This news release contains forward-looking statements and forward-looking information within the meaning of
applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing",
"may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking
information or statements. The forward-looking statements and information are based on certain key expectations and assumptions
made by the Corporation. Although the Corporation believes that the expectations and assumptions on which such forward-looking
statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and
information because the Corporation can give no assurance that they will prove to be correct. Since forward-looking
statements and information address future events and conditions, by their very nature they involve inherent risks and
uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Other
factors, which could materially affect such forward-looking information are described in the risk factors in the Corporation's most
recent annual management’s discussion and analysis that is available on the Corporation’s profile on SEDAR at www.sedar.com.
Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news
release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news
release are made as of the date hereof and the Corporation undertakes no obligation to update publicly or revise any
forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required
by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in
policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2019 TheNewswire - All rights reserved.